File(s) not publicly available
Immunotherapy of cancer by antisense inhibition of Ii protein, an immunoregulator of antigen selection by MHC class II molecules
Version 2 2024-06-06, 18:27
Version 1 2023-05-26, 05:33
journal contribution
posted on 2024-06-06, 18:27 authored by MZ Xu, XQ Lu, NL Kallinteris, Y Wang, SZ Wu, E von Hofe, JV Gulfo, RE Humphreys, GG HillmanImmunotherapy of cancer by antisense inhibition of Ii protein, an immunoregulator of antigen selection by MHC class II molecules
History
Journal
CURRENT OPINION IN MOLECULAR THERAPEUTICSVolume
6Pagination
160-165Location
EnglandISSN
1464-8431eISSN
2040-3445Language
EnglishPublication classification
CN.1 Other journal articleIssue
2Publisher
THOMSON REUTERS (SCIENTIFIC) LTDUsage metrics
Categories
No categories selectedKeywords
Science & TechnologyLife Sciences & BiomedicineBiotechnology & Applied MicrobiologyMedicine, Research & ExperimentalResearch & Experimental Medicinecancer vaccineIi antisenseimmunotherapymajor histocompatibility complex class IIT-helper cellsT-CELLSINVARIANT CHAINTUMOR-CELLSDENDRITIC CELLGENE-TRANSFEREXPRESSIONVACCINESTHERAPYCOMPLEXIDENTIFICATION
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC